Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Blog
  • Small Molecule Drug Discovery
  • Optimizing experimental efficiency with multiplex immunoassays.
cell analysis blog 8 multiplexing hero

Blog

Small Molecule Drug Discovery

Jul 3rd 2024

2 min read

Optimizing experimental efficiency with multiplex immunoassays.

Help us improve your Revvity blog experience!

Feedback

Immunoassays are powerful analytical techniques for quantifying analytes in biological samples, providing critical information for diagnostics, research, and quality control. While single-target, single-readout (monoplex) immunoassays have traditionally been the go-to method for protein and biomolecule quantification in drug discovery research, the introduction of multiplexing has expanded the scope of scientific enquiry for many researchers. 

Monoplex assays, such as AlphaLISA™ and HTRF™, are still relied upon for their simplicity and reliability, but multiplexing has emerged as a complementary technique, offering a wider array of research possibilities. By allowing multiple readouts from a single well, multiplexing not only optimizes experimental efficiency but also provides opportunities to gain greater insights into complex biological systems. 

Multiplex assays can be used for the investigation of various aspects of biology, including compound mechanism of action studies, bispecific antibody analysis, and cytokine modulation studies. Examples of multiplex applications include: 
 

  • Mechanism of action studies: Multiplex assays can be used to facilitate the study of compound mechanisms of action along signaling pathways. For instance, a dual phospho detection assay can be used to simultaneous detect and quantify phosphorylated forms of a protein at different phosphorylation sites. Such information can prove useful for determining the function of a protein or gaining insights into downstream signaling pathways.
  • Bispecific antibody analysis: Bispecific antibodies, with their dual binding properties, may enable superior efficacies compared to their monospecific counterparts. However, it is important to appropriately analyze the binding properties of both domains. Multiplex assays offer a solution by enabling the simultaneous assessment of the affinities of both binding domains of a bispecific antibody.
  • Cytokine modulation studies: In the field of cytokines, multiplex assays can be used to simultaneously measure multiple cytokines within the same sample. This capability is particularly valuable in cytokine modulation studies, where the goal is to identify compounds that selectively inhibit the secretion of a particular cytokine without affecting the secretion of others.

Measuring multiple targets from the same well is particularly beneficial when working with limited or expensive sample materials, such as serum, plasma, or cerebrospinal fluid (CSF). This not only conserves precious samples but also reduces the need for additional reagents and person-hours associated with running individual assays, thereby saving valuable time and costs. 

Multiplex assays are also valuable for improving data quality by enabling additional parameters for normalization. By measuring multiple targets within the same sample, researchers can account for variations in sample handling, processing, and experimental conditions. For instance, multiplex assays enable researchers to normalize phosphorylation data relative to total protein content in the sample, reducing the risk of false positives or negatives, or incorrect classification of a compound’s mechanism of action. 
To find out more about multiplex immunoassays, watch our video below.

 

blog 8 multiplexing


Technologies to advance multiplex assays

Technologies such as AlphaPlex™ and LEGENDplex™ represent some of the innovative approaches for advancing multiplex assays. 

AlphaPlex allows researchers to transition from established AlphaLISA methods to multiplexed detection of a wide array of biomarkers. By utilizing multiple AlphaPlex acceptor beads tailored to various analytes, each with distinct fluorescent properties, these assays can be developed to monitor the presence of multiple targets in the same well. 

Another innovative technology is LEGENDplex, which allows researchers to quantify cytokines using standard flow cytometers. By utilizing beads pre-coated with antibodies for their intended target, cytokine concentrations can be reliably quantified.

For research use only. Not for use in diagnostic procedures.
 

Learn more

Help us improve your Revvity blog experience!

Feedback

Share this post:

  • Email
  • Facebook
  • Linkedin
  • Twitter

続き Small Molecule Drug Discovery posts

Microfluidic electrophoresis for nucleic acid and protein analysis.
Read
Optimizing assay duration in cell panel screens for slow-acting therapeutics.
Read
Top tips for getting started with antibody validation using cell lines.
Read

Questions?
We’re here to help.

Contact us
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.